PortfoliosLab logo

Actinium Pharmaceuticals, Inc. (ATNM)

Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US00507W2061
CUSIP
00507W206

ATNMPrice Chart


Chart placeholderClick Calculate to get results

ATNMPerformance

The chart shows the growth of $10,000 invested in Actinium Pharmaceuticals, Inc. on Jun 27, 2013 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $578 for a total return of roughly -94.22%. All prices are adjusted for splits and dividends.


ATNM (Actinium Pharmaceuticals, Inc.)
Benchmark (S&P 500)

ATNMReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD-7.65%-3.97%
1M-20.71%-0.94%
6M-21.50%7.48%
1Y-33.13%21.47%
5Y-28.94%15.05%
10Y-28.68%13.16%

ATNMMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ATNMSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Actinium Pharmaceuticals, Inc. Sharpe ratio is -0.59. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


ATNM (Actinium Pharmaceuticals, Inc.)
Benchmark (S&P 500)

ATNMDividends


Actinium Pharmaceuticals, Inc. doesn't pay dividends

ATNMDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ATNM (Actinium Pharmaceuticals, Inc.)
Benchmark (S&P 500)

ATNMWorst Drawdowns

The table below shows the maximum drawdowns of the Actinium Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Actinium Pharmaceuticals, Inc. is 98.67%, recorded on Mar 18, 2020. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.67%Apr 24, 20141486Mar 18, 2020
-32.81%Oct 2, 201327Nov 13, 20133Nov 18, 201330
-32.13%Dec 11, 20139Dec 23, 201352Mar 12, 201461
-21.74%Aug 29, 20132Aug 30, 201310Sep 17, 201312
-11.84%Aug 2, 20133Aug 19, 20131Aug 21, 20134
-11.51%Mar 26, 20141Mar 26, 20143Mar 31, 20144
-10.99%Nov 19, 20135Nov 25, 20131Nov 26, 20136
-10.7%Apr 4, 20142Apr 7, 201411Apr 23, 201413
-5.71%Jul 11, 20131Jul 11, 20135Jul 29, 20136
-4.17%Mar 17, 20142Mar 18, 20145Mar 25, 20147

ATNMVolatility Chart

Current Actinium Pharmaceuticals, Inc. volatility is 55.69%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ATNM (Actinium Pharmaceuticals, Inc.)
Benchmark (S&P 500)

Portfolios with Actinium Pharmaceuticals, Inc.


Loading data...

More Tools for Actinium Pharmaceuticals, Inc.